Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury

Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury

Each year, more than two million babies die or evolve to permanent invalidating sequelae worldwide because of Hypoxic-Ischemic Brain Injury (HIBI). There is no current treatment for that condition except for therapeutic hypothermia, which benefits only a select group of newborns. Preclinical studies...

Full description

Bibliographic Details
Main Authors: José Martínez-Orgado, María Villa, Aarón del Pozo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Pharmacology
Subjects:
cannabidiol
hypoxia-ischemia
neuroprotection
brain
newborn
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.584533/full

Similar Items

Similar Items